$BLUE Form 8-K

0
544

Form 8-K for BLUEBIRD BIO, INC.


22-Jun-2015

Other Events, Financial Statements and Exhibits

Item 8.01Other EventsOn June 22, 2015, bluebird bio, Inc. (“bluebird”), and Kite Pharma, Inc. (“Kite”) issued a joint press release announcing that they have entered into a collaboration agreement to advance second generation T cell receptor product candidates to treat certain cancers associated with human papillomavirus. The full text of the press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 9.01Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.   Description
99.1          Press release issued by bluebird bio, Inc. and Kite Pharma, Inc. on June
              22, 2015

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here